Pondicherry Journal of Nursing

Register      Login

VOLUME 16 , ISSUE 4 ( October-December, 2023 ) > List of Articles

REVIEW ARTICLE

Asherson's Disease

Kounassegarane Deepika

Keywords : Antiphospholipid syndrome, Asherson's disease, Coagulation factor, Hereditary

Citation Information : Deepika K. Asherson's Disease. 2023; 16 (4):85-87.

DOI: 10.5005/jp-journals-10084-13179

License: CC BY-NC 4.0

Published Online: 10-01-2024

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Asherson's disease is a rare autoimmune disorder. It affects the anticoagulation mechanism of blood. The exact cause of the disease is unknown but it may be due to antiphospholipid (APL) syndrome, hereditary, and gene transformation. This disease may affect all organs in the human body. There is no cure for the disease and no exact medicine has been identified. Supportive treatment is given to promote the betterment of the individual with Asherson's disease.


HTML PDF Share
  1. Arakelyan HS, Forghanisardaghi M. Asherson's syndrome-catastrophic antiphospholipid syndrome. 2019.
  2. Asherson RA. The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmunity Reviews 2019;6(2):64–67. DOI: https://doi.org/10.1016/j.autrev.2006.06.005.
  3. Asherson's syndrome [online]. National Organizations for Rare Disorders. Available at: https://rarediseases.org/rare-diseases/ashersons-syndrome/.
  4. Cervera R, Asherson RA. Catastrophic antiphospholipid (Asherson's) syndrome. British Journal of Hospital Medicine 2019;69(7):384–387. DOI: https://doi.org/10.12968/hmed.2008.69.7.30413.
  5. Cervera R, Font J, Gómez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 1998;77(3):195–207. DOI: 10.1097/00005792-199805000-00005.
  6. Sciascia S, Lopez-Pedrera C, Roccatello D, Cuadrado MJ. Catastrophic antiphospholipid syndrome (CAPS). Best Practice and Research: Clinical Rheumatology 2012;26(4):535–541. DOI: 10.1016/j.berh.2012.07.005.
  7. Cervera R, Font J, Gomez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005;64:1205–1209. DOI: 10.1136/ard.2004.025759.
  8. Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms. Autoimmunity Reviews 2019;10(2):74–79. DOI: 10.1016/j.autrev.2010.08.005.
  9. Makatsariya A, Khizroeva J, Bitsadze V. Catastrophic antiphospholipid syndrome (Ronald Asherson syndrome) and obstetric pathology. Journal of Perinatal Medicine 2020;46(4):387–400. DOI: https://doi.org/10.1515/jpm-2017-0092.
  10. Misita CP, Moll S. Antiphospholipid antibodies. Circulation 2005;112:e39–44. DOI: 10.1161/CIRCULATIONAHA.105.548495.
  11. Ortel TL, Kitchens CS, Erkan D, Brandão LR, Hahn S, James AH, et al. Clinical causes and treatment of the thrombotic storm. Expert Review of Hematology 2020;5(6):653–659. DOI: 10.1586/ehm.12.56.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.